Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
“Het voornaamste doel bij post-COVID is symptoomverlichting, vaak niet-medicamenteus”
jun 2026 | Virale infecties